Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Rigel Pharmaceuticals
- Study ID
- NCT00446095
- Phase
- PHASE1/PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- fostamatinib — DRUG200 mg PO BID
Study Details
Patients: B-cell lymphoma, refractory, diffuse, nodular, mantle, other Phase I : Two groups of 6 patients, escalating dose tolerability- 28 days Phase II: Three groups of 16 patients (nodular, diffuse large cell, mantle cell plus others). Oral bid dosing with highest tolerable dose until toxicity, progression, or withdrawal
Key Dates
- Start date
- Apr 30, 2007
- Status verified
- Aug 2016
- Primary completion
- Apr 30, 2010
- Completion
- Oct 31, 2010
Study Design
- Enrollment
- 81 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: fostamatinib
Primary Outcome Measure
Overall Response Rate as Assessed According to the"Revised Response Criteria for Malignant Lymphoma" (Cheson 2007). [ Time Frame: Serial tumor assessments were taken at baseline (within 28 days of the start of treatment), and re-evaluated at Day 57, and every 12 weeks thereafter or to confirm response . (Maximum duration of treatment 511 days, Maximum duration of follow-up 812 Days) ]
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Los Angeles | California | 90095 | - |
| Research Site | Stanford | California | 94305 | - |
| Research Site | Atlanta | Georgia | 30322 | - |
| Research Site | Chicago | Illinois | 60612 | - |
| Research Site | Indianapolis | Indiana | 46202 | - |
| Research Site | Boston | Massachusetts | 02115 | - |
| Research Site | Rochester | Minnesota | 59905 | - |
| Research Site | Omaha | Nebraska | 68198 | - |
| Research Site | New York | New York | 10065 | - |
| Research Site | Rochester | New York | 14642 | - |
| Research Site | Cleveland | Ohio | 44195 | - |
Find similar trials in Los Angeles, CA
Related Studies
- Bone Marrow Grafting for Leukemia and LymphomaEnrolling By Invitation · Stanford University · Stanford, California
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado